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Abstract
Aims and objectives This study aimed to analyse the key factors that influence the overimaging using X-ray such as self-
referral, defensive medicine and duplicate imaging studies and to emphasize the ethical problem that derives from it.
Materials and methods In this study, we focused on the more frequent sources of overdiagnosis such as the total-body CT, 
proposed in the form of screening in both public and private sector, the choice of the most sensitive test for each pathology 
such as pulmonary embolism, ultrasound investigations mostly of the thyroid and of the prostate and MR examinations, 
especially of the musculoskeletal system.
Results The direct follow of overdiagnosis and overimaging is the increase in the risk of contrast media infusion, radiant 
damage, and costs in the worldwide healthcare system. The theme of the costs of overdiagnosis is strongly related to inap-
propriate or poorly appropriate imaging examination.
Conclusions We underline the ethical imperatives of trust and right conduct, because the major ethical problems in radiology 
emerge in the justification of medical exposures of patients in the practice. A close cooperation and collaboration across all 
the physicians responsible for patient care in requiring imaging examination is also important, balancing possible ionizing 
radiation disadvantages and patient benefits in terms of care.
Keywords Overimaging · Overdiagnosis · Ethics · Radiation protection
Introduction
The field of biomedical imaging, in particular the area of 
radiology, has expanded intensely over the last decade. The 
contemporary role of the radiologist is being challenged as 
the use of images by clinicians is continuously increasing.
The development of medical imaging over the past two 
decades has produced undisputable benefits to patients in 
terms of life expectancy and quality of life [1]. This evolu-
tion reflects the utilization of complex ionizing and non-
ionizing radiation technologies such as multidetector com-
puted tomography (MDCT), positron emission tomography 
(PET), and magnetic resonance imaging (MRI). Part of such 
growth, however, can be attributed to the overuse of imag-
ing services.
Overuse can be defined as the application of imaging pro-
cedures where conditions clearly show that they are unlikely 
to increase the patient outcome.
Key factors influencing imaging overuse include: the 
practice behaviour of referring physicians, self-referral 
(including referral for additional radiological examinations), 
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duplicate imaging studies, defensive medicine, missed edu-
cational opportunities when inappropriate procedures are 
requested, patient demand, payment mechanisms, and finan-
cial incentives (as in the US healthcare system) [2].
Self-referral was known since 1920s, well before the 
advent of high technology in radiology, but observers gen-
erally agree its volume has increased in the last 20–30 years 
[3]. Self-referral can be manifested in two main ways forms: 
a physician who is not an imaging specialist (or a non-phy-
sician provider) referring patients to his or her own on-site 
imaging services represents the first form of self-referral; the 
second form of self-referral consists of physicians referring 
their patients to outside facilities in which they has personal 
a financial interest. Self-referral denotes a conflict of inter-
est for the referring physician when the financial profit from 
conducting the procedure may prevail, the medical necessity 
of the procedure.
Defensive medicine has been defined as diagnostic or 
therapeutic actions applied mainly to safeguard against 
potential claims of malpractice rather than to benefit the 
patient. Defensive medicine represents a severe and wide-
spread challenge in contemporary medicine, and it is a major 
cause of overuse of imaging, i.e. its application has a low 
probability to improve patient outcome. The problems are 
the concerns of missing unexpected or rare findings and fear 
from litigation; other reasons are avoidance of an inaccurate 
diagnosis or keeping costs low. Defensive ordering of diag-
nostic examinations may additionally lead to overdiagnosis, 
which is the detection of new findings not associated with 
a significant impact on health which in turn may determine 
further unnecessary actions [4].
Discussion
Imaging services using ionizing radiation (i.e. whole-body 
CT) are progressively being marketed directly to the public, 
often with encouragement to individuals to “self-present” 
to imaging facilities for specific studies [5]. Too often these 
studies are expensive and provide doubtful benefits to indi-
viduals undergoing them. Moreover, physicians should 
encourage patients to report imaging examinations they have 
undergone previously in order to avoid duplicate studies. 
Imaging studies are often duplicated when efforts to iden-
tify previous examinations are insufficient or unproductive. 
Duplicate studies contribute to overuse of medical imaging 
[6].
Recent research shows that approximately one-third of 
healthcare spending is duplicative, is unhelpful, or makes 
patients worse [7]. Unnecessary imaging studies rarely 
reveal the cause of patients’ complaint, yet may disclose 
incidental findings, which necessitate further imaging or 
interventional procedures to be clarified [8]. Diagnostic 
imaging by itself does not improve patient health and pro-
vides no intrinsic value to patients. The only possible benefit 
of imaging is secondary to a change in patient treatment. 
Therefore, understanding the value of imaging requires 
incorporating imaging into a framework of medical deci-
sion‐making and selection of correct therapy. Moreover, 
diagnostic imaging will always have the potential to lead 
to false‐positive and false‐negative diagnoses. Therefore, 
imaging information must not be considered absolute, but 
rather must be understood inside a specific clinical context 
including the patient history, previous radiological examina-
tions, and other clinical data to form a combined picture that 
reasonably either confirms or excludes a given diagnosis [9].
Because of the possible self‐interest by policy makers, 
payers, physicians, imaging industry, and patients, it clearly 
emerges the ethical imperatives of trust and right conduct. 
Overuse of medical imaging increases unsustainable costs 
in the worldwide healthcare systems and exposes both single 
individuals and general population to unnecessary radiation 
doses [10]. It is clear that a serious part of the increasing 
healthcare costs and fragmentation of medical care resides in 
cooperation and collaboration across many sectors, includ-
ing radiologists, industry, referring clinicians, healthcare 
service payers, and public interest groups.
The bioethical principle of distributive justice holds that 
healthcare resources should be distributed as equitably as 
possible. Given finite resources for health services, it is 
unethical to provide expensive non-essential health services 
to one sector of the society when another sector lacks of 
essential services [11]. Despite persistent inequity in the 
distribution of healthcare resources in the USA, we should 
ask about new medical interventions, “Does this test or treat-
ment undermine the fair distribution of health resources?” 
Given the importance of this subject and the magnitude 
of its potential economic impact, it is important to restore 
objectivity.
Speaking more in deep about radiological protection, we 
daily deal not only with useless or inappropriate examina-
tions, but with imaging modalities which may themselves 
lead to detrimental effects on patients, especially when 
using contrast media administration and radiation exposure. 
Indeed, the major ethical problems in radiology emerge in 
the justification of medical exposures of patients in the prac-
tice. The medical exposure of patients is intentional and with 
the expectation for a direct individual health benefit to the 
patient. With respect to other planned exposure situations, 
the justification lies more often with the profession, rather 
than with government or regulatory authorities, and the final 
responsibility for the justification, in the use of a particu-
lar procedure, lies with the relevant physician, who should 
be aware of risks and benefits of the involved procedures 
[12, 13]. In case of radiological examinations exceeding the 
needs of good medical practice, the only result may be an 
La radiologia medica 
1 3
unjustifiable possible risk for patients, not providing any real 
benefit, with the result of inconvenience application of the 
main principles of radiological protection and medical ethics 
[14]. The potential risks and the uncertainties regarding the 
risk associated with radiation exposures have a significant 
role in the decision to undertake a procedure, and also the 
complexity, in communicating the risk, has to be taken into 
consideration. In fact, informed consent is more than sim-
ply getting a patient to sign a written consent form, it is a 
communication process, which requires additional time for 
a real and comprehensive informed consent, and this is also 
related to the critical question of having the proper time 
to dedicate to the individual patients. Value judgements on 
appropriateness of a procedure require knowledge on the 
implications of the act and about the ethical and societal val-
ues on which to base the decisions for that act. The system of 
radiological protection developed by the International Com-
mission on Radiological Protection (ICRP) has evolved and 
continues to evolve on the basis of three recognized pillars: 
science of radiological protection, a set of ethical values, 
and experience accumulated from the daily practice of radio-
logical protection by professionals [15, 16]. It is evident that 
quantifying benefits and harms is often problematic and the 
threshold between an appropriate and an inappropriate act 
can vary among patients and patient groups [17]. It is also 
evident that ethics alone cannot offer a definitive solution to 
questions and dilemmas, but it can certainly provide useful 
insights into the principles and philosophy of radiological 
protection. In such way, it can be of help in the dialogue 
among experts, and among experts, patients, and people, to 
highlight values and preferences in view of a positive bal-
ance between potential benefits and harms.
Regarding the ethical dimension of radiological protec-
tion, it is worthwhile to mention the contribution by Gio-
vanni Silini, who reviewed the ethical foundation of the 
radiological protection system in his Sievert Lecture, in 
1992 [18], by emphasizing that the system has been ration-
ally developed and, at the same time, with the desire to act 
reasonably. In radiological protection, the core ethical val-
ues, as addressed in the recent ICRP Publication on Ethi-
cal Foundations of the System of Radiological Protection 
[15], support the aims of the radiological protection system 
and its three fundamental principles: justification, optimiza-
tion, and individual dose limitation. Four ethical values are 
recognized underpinning the current system of protection: 
beneficence/non-maleficence, prudence, justice, and dignity. 
As well known, the origin of medical ethics lies with Hippo-
cratic oath and more recent with the approach by Beauchamp 
and Childress [19, 20] given through the four principles of 
biomedical ethics: autonomy, the right of patients to make 
their own choice; beneficence, to act taking in mind the best 
interest for the patient; non-maleficence, to consider not to 
harm; justice, to be fair. The core ethical values recognized 
in the system of radiological protection are clearly consistent 
with the principles of biomedical ethics, when considering 
beneficence and non-maleficence in one single concept; the 
autonomy replaced by dignity; and the addition of prudence.
Overimaging as applications of imaging procedures 
where circumstances indicate that they are unlikely to 
provide additional positive outcomes for the patient may 
increase the average dose to the population resulting from 
medical exposures. Given the moral obligation of healthcare 
providers, “first, do not harm”, the ethical indication is to 
lower the risk, with benefit outweighing the risk, by consid-
ering procedures appropriately prescribed and appropriately 
performed (justification and optimization) [21]. At the same 
time, there is an ethical relevance related to benefit to the 
society, which is not achieved and quite disregarded, if an 
unbalance between health outcome and corresponding costs 
is created [22–24].
Supply and demand are considered the main mechanisms 
at the base of overimaging. Expanded availability of tech-
nological medical procedures and increased demand from 
patients/individuals, together with referring clinicians for 
assurance, can create the feeling and perception of imag-
ing as a mean to comfort patients and clinicians, where the 
benefits may easily be overestimated, while risks and costs 
are somewhat neglected [25]. Individual health assessment 
which is addressed in the last European directive on radia-
tion protection (BSS) could also play a role in increasing 
unnecessary examinations.
The obligation to benefit the patient must be balanced 
against the obligation not to cause harm, with the purpose 
of ensuring that benefits will outweigh, harms (beneficence, 
non-maleficence) [26] and the attention to these ethical val-
ues may become a difficult task if the risks are uncertain, as 
for the low doses. Overestimation of risks might result in 
not performing an imaging procedure that could be of ben-
efit and underestimation of risk might result in an increase 
in risk for patient and society without any advantage for 
the patient [27, 28]. Decision-making under uncertainties 
requires prudence as a central value. Prudence should not 
be taken as synonymous of conservatism or “never taking 
risk”, but it defines and sustains the way in which decisions 
are made, and it does not refer only to the outcome of those 
decisions. We can say that prudence represents the ability 
to take an informed and well-considered decision under 
uncertainty, without having a full knowledge of the conse-
quences of the undertaken action. The justification principle 
combines the ethical values of beneficence and non-malefi-
cence, with the ethical value of prudence. A prudent ethical 
practice accompanied with proper communication is part of 
justification and important, where relevant, to avoid possible 
overimaging [21]. Justice, as core value, requires an equita-
ble treatment for all. A proper imaging examination, at the 
right time, with attention to justification and optimization, 
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can have significant value for the patient and the society, 
while overutilization of imaging brings inappropriate use 
of resources that could be used for other medical purposes, 
thus violating the justice in the distribution of advantages 
and disadvantages. Justice relates our sense of fairness, and 
we can say that considering radiation risk a particular atten-
tion has to be given to avoid overimaging children in view 
of their higher risk of adverse effects of radiation, compared 
with adult [28].
This is particularly true when considering the exponen-
tial increase in radiological examinations during the last 
decades, and the consequent increased number of imaging 
findings which are not related to the original “diagnostic 
dilemma”. Indeed, market research studies have shown 
that in the USA the number of computed tomography (CT) 
examinations increased from 3 million/year in 1980 to 6 
million/year in 2006; the actual estimated increased rate is 
between 8 and 10%/year [29–31].
It also results from the Medicare program (reimbursing 
diagnostic imaging services in the USA) that during this 
period CT scans of the abdomen tripled and those of the tho-
rax quintupled. Furthermore, the number of magnetic reso-
nance imaging (MRI) studies is constantly increasing, with 
brain examinations rising by fourfold, spinal examinations 
by sixfold, and knee examinations by tenfold [32]. In the pri-
vate sector, many studies have now started to offer screening, 
performed using whole-body CT. A recent study reported 
that in these tests, in 68% of the cases, abnormalities caus-
ing no symptoms, called incidentalomas, were detected [32, 
33]. The most common ones are lung nodules. Small lung 
nodules are found in 15% of non-smokers and up to 50% of 
smokers [34]. Of course, a finding in a non-symptomatic 
patient causes negative psychological effects on the patient.
In this regard, for example, it is reported that the risk of 
death for a liver biopsy performed for the purpose of inves-
tigating an incidentaloma (from about 1–2 per 1000 to 4) 
is of the same order of magnitude as the probability that 
incidentaloma is a deadly tumour [35].
Also, in the field of CT, an important aspect concerns 
the detection of anomalies affecting venous circulation and 
their possible consequences at the pulmonary level. In fact, 
the prevalence of pulmonary embolism is significantly influ-
enced by the diagnostic tests performed, while from a clini-
cal point of view, few patients with venous thrombosis of the 
lower limbs have respiratory disorders [36].
Currently in most cases, nuclear medicine was replaced 
by the spiral CT. This investigation, in patients with throm-
bosis of the peripheral veins of the lower limbs, identifies 
34% more patients with micro pulmonary embolisms com-
pared to the nuclear medicine test [37]. Therefore, although 
CT increases the micropulmonary embolisms detection rate 
[38], it also entails the risk of contrast media injection, radi-
ation exposure, and increased costs [39].
Ultrasound investigations can also be a source of overdi-
agnosis. For example, it is reported that about 10% of indi-
viduals without any symptoms can present gallbladder stone 
on ultrasound examination [40]. A more relevant problem, 
even for biological and economic costs, is the occasional 
finding of a thyroid nodule in asymptomatic patients, occur-
ring in 67% of patients. However, the 10-year mortality risk 
of thyroid cancer is only 0.005%. The true probability that 
incidentaloma is actually a cancer is < 0.01% [41]. Occa-
sional finding of thyroid nodules almost always leads to 
the request of at least one subsequent follow-up test, if not 
directly to the direct execution of a fine needle aspiration. 
In this way, the economic cost of a thyroid ultrasound study 
is systematically (at least) doubled. Another of the most 
commonly discussed topics is the overdiagnosis of prostate 
cancer. The diffusion of transrectal ultrasound (TRUS) and 
TRUS-guided biopsy has led to a clear increase in the diag-
nosis, without, however, significant effects on reduction in 
mortality rate. The number of identified prostatic neoplasms 
is directly proportional to the number of samples taken. One 
study showed that performing six samples in symptomatic 
patients, no neoplasm was found, but referring the same 
patients to “saturation biopsy” with 32–38 samples, prostate 
cancer was detected in 14% [42].
The American Cancer Society has recently stated that 
prostate cancer has a slow growth and no tests should 
be done in men who have a life expectancy of less than 
10 years. A recent US study even states that screening pro-
grams would increase prostate cancer mortality by 13%, as 
a result of post-surgical and therapeutic complications in 
patients who would otherwise have not undergone any treat-
ment [43].
Professor Albin, the discoverer of the PSA, recently pub-
lished in the New York Times an article entitled “The great 
error of the prostate” stating that unfortunately PSA test fails 
to distinguish between two types of prostate cancer: the one 
that can develop up to be mortal and the other one which 
remains silent [44]. Ulterior source of overdiagnosis is MR 
examinations, especially of the musculoskeletal system. 
Approximately 40% of people undergoing MRI of the knee, 
despite being substantially asymptomatic, may have menis-
cal injuries [45, 46]. Approximately 50% of people undergo-
ing MRI of the lumbar spine, although without significant 
symptoms in the back, may have disc protrusions [47].
The matter of the costs of overdiagnosis is then strongly 
correlated with that of inappropriateness. In Italy, a sector 
study has shown a rate of inappropriateness in outpatient 
radiology requests of 44% [48].
The Chairman of the Italian Society of Medical and Inter-
ventional Radiology (SIRM), in a recent article, confirmed 
that in the country one-third of the radiological investiga-
tions performed is inappropriate [49]. Calculating that in 
Italy about 100 million radiological examinations per year 
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are performed and that the average cost of radiological ser-
vices, taking into account the various types, is about 80 €, it 
is likely to estimate the economic value of the inappropriate 
tests in about 3 billion EUR/year.
But now, we must consider the most human and important 
factor of overdiagnosis and overusing of medical radiologi-
cal examinations: the inappropriate and potentially useless 
radiation exposure of the population, without any improve-
ment of cost/benefit ratio.
The overuse of medical imaging, when involves methods 
delivering ionizing radiation, increases the radiation expo-
sure and thus the associated risks such as cancer induction 
[50, 51]. The risk of overdiagnosis is particularly important 
in the setting of cancer screening or emergency [52–54].
This is a critical issue in screening mammography. It 
refers to detected cancers that would have not progressed to 
become clinically evident during the patient lifetime [55]. In 
particular, overdiagnosis is associated with ductal carcinoma 
in situ, a rare tumour (less than 5% of the annual incidence 
of breast cancers) which progresses to invasive disease in a 
wide time frame ranging between 5 and 15 years according 
to the grade. The estimation of this phenomenon in this set-
ting is extremely difficult as demonstrated by a wide range of 
rates from 0 up to 30%. According to European data, it can 
range between 1 and 10% [56]. The impact of overdiagnosis 
on radiation exposure is extremely difficult to estimate. It 
has been evaluated that the mean glandular dose for screen-
ing mammography ranges between 3 and 10 mGy and it is 
mainly influenced by the number of views acquired, the tech-
nology used and by patient-related factors [57, 58]. Despite 
the radiation exposure level, it has been demonstrated that 
the number of deaths caused by radiation-induced cancers 
is around 125–208 time smaller than the lives saved owing 
to screening [58, 59].
Another setting where this issue is critical is lung cancer 
screening with low-dose computed tomography (LDCT) 
since the rate of detected cancers not evolving in clinically 
relevant disease ranges between 10.99 and 25.83% [60, 61]. 
In this setting, the number of false positive is also crucial 
since it has been demonstrated that 9.2–51% of positive 
controls at the first round turns to be a false positive which 
become 21% at the second round and 33% at the third round 
determining 2.3% of minor and 2.73% of major invasive pro-
cedures [63, 64]. More important, in around 50% of screened 
patients an incidental finding is detected 7.5% of which turns 
to be clinically significant [65]. Overdiagnosis, false posi-
tives, and incidental findings increase the number of imaging 
examination with a consequent radiation exposure increase. 
The average dose exposure reported in large screening trials 
for a single low-dose computed tomography ranges between 
0.61 and 1.5 mSv and it increases by 4 mSv if a PET-CT 
is acquired [66]. Thus, the cumulative risk of cancer inci-
dence, attributable to radiation exposure, according to the 
BEIR VII report [66], after 10 years of CT screening, is 
0.05%; in other words, one radiation-induced lung cancer 
should be expected every 173 detected cancer and one radi-
ation-induced major cancer every 108 lung cancer detected 
through screening [67]. Since the effect of screening on lung 
cancer mortality has been estimated to be about 5%, the risk 
of radiation-induced cancer can be considered acceptable 
[60, 62, 66].
The last major setting where overdiagnosis increases 
overuse and thus radiation exposure is the field of emer-
gency. In particular, the use of computed tomography has 
increased fourfold in the last 10 years for any clinical condi-
tion such as trauma, pulmonary infections, abdominal pain, 
and pulmonary embolism [53, 68]. The indiscriminate use of 
computed tomography determines an increase in incidental 
findings leading to a costly and potentially harmful diagnos-
tic, therapeutic, or interventional cascade [68]. The estima-
tion of overdiagnosis in emergency imaging is extremely 
difficult to evaluate, and there is no evidence in literature. 
Even more complex is to determine its impact on radiation 
exposure, which should be considered proportional to the 
increase in unjustified imaging examinations. In a recent 
survey, over 85% of emergency physicians interviewed felt 
that 22% of advanced imaging studies ordered were not 
clinically justified.
Conclusion
While the radiation exposure risks related to screening 
imaging seem justified by the benefit of a greater mortal-
ity reduction, despite the negative influence of not negligi-
ble overdiagnosis, in the setting of emergency imaging this 
phenomenon as well as overuse negatively influences the 
radiation exposure of patients without the compensation of 
clinical benefits.
In practice, searching for reasonableness and tolerabil-
ity is a permanent effort directed to act wisely, based on 
accumulated knowledge, ethical values, and experiences. A 
careful and adequate communication and empathy to the 
patient, adding a co-involvement of the patient her/himself 
in the decision-making process, can be of help towards the 
best choice for the patient’s well-being.
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